Continuous drug substance manufacturing from biomass-derived building blocks BAA pmqwp #356.

Active Definitive Contract Awarded Last action

Contract number
75F40122C00192
Awardee
Awarding agency
Obligated
$3,000,000

Award facts

Opportunity
Contract value 100% obligated
$3,000,000.00 Current and potential, with all options
Completion date 82% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 165 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00004 · EO 14398 - the purpose of this modification is to: the vendor requests an extension of 12 months for this project. $0
Other Administrative Action P00003 · MOD P00003 - the purpose of this modification is to: the vendor requests an extension of 12 months for this project. $0
Other Administrative Action P00002 · The purpose of this modification is to: the vendor requests an extension of 12 months for this project. $0
Other Administrative Action P00001 $0
Original award $3,000,000

About this award

The Food and Drug Administration awarded a $3 million cost-plus-no-fee definitive contract to National Institute For Pharmaceutical Technology & Education Inc. (doing business as Nipte) for continuous drug substance manufacturing from biomass-derived building blocks on September 22, 2022. The contract ceiling is $3 million, with an ultimate completion date of September 28, 2027. This award reflects a 12-month extension requested by the vendor.

The originating Broad Agency Announcement sought research and development proposals to advance regulatory science across nine areas of interest, with the intent to develop new tools, standards, and approaches supporting safety, efficacy, and quality evaluations of FDA-regulated products. Place of performance is Silver Spring, MD 20993. Nipte is a non-profit collaboration of academia, industry, and other stakeholders focused on pharmaceutical technology research and education.

Quick answers

Who was awarded contract 75F40122C00192?

75F40122C00192 was awarded to National Institute For Pharmaceutical Technology & Education Inc. by Food and Drug Administration (Department of Health and Human Services) on September 22, 2022.

How much is contract 75F40122C00192 worth?

The government has obligated $3,000,000 on 75F40122C00192.

Was contract 75F40122C00192 competed?

The extent of competition for 75F40122C00192 was full and open competition. The government received 165 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award